Saturday 13 October 2012

Secukinumab Shines in Small MS Trial (CME/CE)

LYON, France (MedPage Today) -- Multiple sclerosis appears to be joining psoriasis and rheumatoid arthritis as potential indications for the anti-IL-17A agent secukinumab (AIN457), results of a small trial suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment